cyproheptadine and dasatinib

cyproheptadine has been researched along with dasatinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldstein, DM; Kondru, RK; Kuglstatter, A; Lou, Y; Owens, TD	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1

Reviews

2 review(s) available for cyproheptadine and dasatinib

Article	Year
Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Catalytic Domain; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Humans; Inflammation; Leukemia, B-Cell; Models, Molecular; Protein Conformation; Protein-Tyrosine Kinases; Structure-Activity Relationship	2012
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Article

Year

Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies.

Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Catalytic Domain; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Industry; Humans; Inflammation; Leukemia, B-Cell; Models, Molecular; Protein Conformation; Protein-Tyrosine Kinases; Structure-Activity Relationship

2012

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016